MediPharm Labs Corp. (TSX:LABS)
Canada flag Canada · Delayed Price · Currency is CAD
0.0650
0.00 (0.00%)
Apr 10, 2026, 2:33 PM EST

MediPharm Labs Ratios and Metrics

Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
282724262051
Market Cap Growth
-33.47%11.08%-6.17%32.09%-60.97%-38.62%
Enterprise Value
16.4516.5913.1810.4-3.7616.71
Last Close Price
0.070.070.060.070.070.19
PE Ratio
--3.25-2.00-1.62-0.64-0.84
PS Ratio
0.610.600.580.790.892.33
PB Ratio
0.770.760.570.490.350.61
P/TBV Ratio
0.760.760.570.450.350.56
P/FCF Ratio
--4.85-4.88-2.04-1.17-3.62
P/OCF Ratio
--4.94-5.04-2.11-1.23-3.83
EV/Sales Ratio
0.360.370.310.31-0.170.77
EV/EBITDA Ratio
--2.45-1.61-0.660.14-0.39
EV/EBIT Ratio
--1.97-1.22-0.570.13-0.34
EV/FCF Ratio
-2.94-2.96-2.63-0.810.22-1.19
Debt / Equity Ratio
0.010.010.010.040.010.00
Debt / EBITDA Ratio
-0.03-0.03-0.05-0.15-0.020.00
Debt / FCF Ratio
-0.04-0.04-0.08-0.18-0.04-0.01
Net Debt / Equity Ratio
-0.30-0.30-0.26-0.30-0.42-0.41
Net Debt / EBITDA Ratio
1.571.571.381.000.880.78
Net Debt / FCF Ratio
1.891.892.251.231.392.42
Asset Turnover
0.910.910.710.510.280.21
Inventory Turnover
3.773.773.063.212.562.23
Quick Ratio
1.851.851.832.203.925.75
Current Ratio
2.772.773.153.379.937.38
Return on Equity (ROE)
-20.93%-20.93%-22.24%-24.00%-43.09%-67.84%
Return on Assets (ROA)
-16.96%-16.96%-18.37%-28.79%-37.43%-46.36%
Return on Invested Capital (ROIC)
-29.55%-29.55%-31.24%-53.37%-72.06%-74.21%
Return on Capital Employed (ROCE)
-21.34%-21.34%-22.45%-33.46%-42.33%-55.13%
Earnings Yield
-29.94%-30.77%-50.00%-61.54%-157.14%-118.92%
FCF Yield
-20.29%-20.61%-20.49%-49.10%-85.72%-27.66%
Buyback Yield / Dilution
-2.53%-2.53%-12.29%-31.23%-10.79%-80.37%
Total Shareholder Return
-2.53%-2.53%-12.29%-31.23%-10.79%-80.37%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.